Oral Status as Predictors of Stroke-Associated Pneumonia and Swallowing Recovery in Patients With Post-Stroke Dysphagia
Launched by UNIVERSITY HOSPITAL, GHENT · Jul 7, 2025
Trial Information
Current as of July 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the health of a person’s mouth might help predict two important things after a stroke: the chance of getting pneumonia (a lung infection) and how well their swallowing improves. After a stroke, many people have trouble swallowing, which can lead to serious problems like pneumonia, poor nutrition, and longer hospital stays. The researchers want to see if things like how clean the mouth is, how strong the tongue is, and how well the teeth support chewing can help identify which patients are more likely to develop pneumonia or have slower swallowing recovery. Understanding this could help doctors better care for stroke patients and support their recovery.
The study will include adults who have had a stroke and are diagnosed with swallowing difficulties, admitted to the stroke unit at Ghent University Hospital in Belgium. Patients must be able to understand and participate in swallowing exercises. Those who join will have their oral health carefully checked, and some will receive routine mouth care to see if it helps with swallowing and chewing. The study is not yet recruiting but will run from 2025 to 2027. This research aims to find simple ways to improve care and recovery for people struggling with swallowing after a stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients admitted to the stroke unit at Ghent University Hospital with ischemic or hemorrhagic stroke who are diagnosed with oropharyngeal dysphagia.
- • Patients over 18 years of age with sufficient cognitive abilities and language skills to understand the swallowing exercises.
- Exclusion Criteria:
- • No exclusion criteria
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gent, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported